title: Optimal dose of prophylactic dexmedetomidine for preventing postoperative shivering.
abstract: OBJECTIVE
  The aim of this study was to investigate the optimum dosage of dexmedetomidine for prevention of postanesthetic shivering.
  
  
  METHODS
  One-hundred thirty two ASA physical status I-II patients scheduled for elective laparoscopic total hysterectomy were enrolled in this randomised, placebo-controlled study. Patients were randomly allocated to receive dexmedetomidine in four groups: group S (0.9% normal saline), group D0.5 (dexmedetomidine 0.5 µg/kg), group D0.75 (dexmedetomidine 0.75 µg/kg), group D1.0 (dexmedetomidine 1.0 µg/kg). Time to extubation and tympanic temperature during and after operation were measured. Shivering was graded (0-3 scale) upon patients arrival to the PACU and every ten minutes thereafter up to forty minutes. Sedation and first rescue analgesic time at the PACU were evaluated.
  
  
  RESULTS
  The incidence of shivering was significantly lower in group D0.75 and D1.0 than in group S (P < 0.05). There were significantly fewer patients with a shivering score of 2 or 3 in groups D0.75 and D1.0 than in group S (P < 0.05, P < 0.001). Extubation time was shorter in group S than in groups D0.75 and D1.0 (P < 0.05). Tympanic temperature at 40 minutes postoperatively in the recovery room was higher in group S than in the other dexmedetomidine groups (P < 0.05) Fewer patients required rescue analgesia in groups D0.75 and D1.0 than in group S (P < 0.001), and the time to rescue analgesia was longer in group D1.0 than in group S (P < 0.001). Modified Observer's Assessment of Alertness/Sedation (MOAA/S) at arrival in the PACU was lower in all dexmedetomidine groups than in group S (P < 0.05).
  
  
  CONCLUSIONS
  Our results suggest that dexmedetomidine 0.75 or 1.0 µg/kg provides effective prophylaxis against postoperative shivering as well as an analgesic effect. Though potential for intraoperative requirement for atropine, sedation in the immediate recovery period and delayed extubation time with dexmedetomidine was noted, there were no major clinical impacts on the overall recovery from anesthesia.
authors: Department of anesthesiology and pain medicine, Catholic University of Korea.
authors: Yong-Shin
authors: YS
authors: Kim
authors: Yong-Il
authors: YI
authors: Kim
authors: Kwon-Hui
authors: KH
authors: Seo
authors: Hye-Rim
authors: HR
authors: Kang
mesh_terms: D000328:Adult; D000698:Analgesia / Q000009:adverse effects*; D020927:Dexmedetomidine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007044:Hysterectomy; D008875:Middle Aged; D012768:Shivering / Q000187:drug effects*
chemical_list: D020927:Dexmedetomidine
keywords: dexmedetomidine; postanesthetic shivering.; sedation
references: Anesthesiology. 1997 May;86(5):1055-60
references: 9158354
references: Middle East J Anaesthesiol. 2002 Oct;16(6):577-85
references: 12503261
references: Anesthesiology. 1987 Mar;66(3):419-21
references: 3826703
references: Paediatr Anaesth. 2007 Apr;17(4):341-6
references: 17359402
references: Anesthesiology. 1995 Aug;83(2):241-9
references: 7631944
references: Br J Anaesth. 2000 May;84(5):615-28
references: 10844839
references: Anaesthesia. 2009 Feb;64(2):141-6
references: 19143690
references: Eur J Anaesthesiol. 2008 May;25(5):357-64
references: 18205960
references: Anesth Analg. 2001 Sep;93(3):620-7
references: 11524329
references: Anesth Analg. 1987 Aug;66(8):751-5
references: 3111305
references: Anesthesiology. 1998 Oct;89(4):878-86
references: 9778005
references: Br J Anaesth. 1993 Nov;71(5):685-8
references: 8251281
references: Eur J Anaesthesiol. 2006 Feb;23(2):149-53
references: 16426470
references: Anesth Analg. 1999 Sep;89(3):652-8
references: 10475299
references: Anesthesiology. 1999 Jun;90(6):1609-16
references: 10360859
references: Br J Anaesth. 2005 Aug;95(2):189-92
references: 15849207
references: Stroke. 2003 May;34(5):1218-23
references: 12690216